Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.
Bluejay Diagnostics, Inc. (BJDX) had Consolidated Net Income/Loss of $-2.32M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-2.32M |
|
-- |
|
-- |
|
$2.35M |
|
$-2.35M |
|
$0.03M |
|
$-2.32M |
|
$-2.32M |
|
$-2.32M |
|
$-2.32M |
|
|
Consolidated Net Income/Loss |
$-2.32M |
$-2.32M |
|
$-2.35M |
|
$-2.30M |
|
2.08M |
|
2.08M |
|
$-1.12 |
|
$-1.12 |
|
| Balance Sheet Financials | |
$9.81M |
|
$1.64M |
|
$1.72M |
|
$11.53M |
|
$2.12M |
|
-- |
|
$0.00M |
|
$2.12M |
|
$9.41M |
|
$9.41M |
|
$9.41M |
|
1.98M |
|
| Cash Flow Statement Financials | |
$-3.09M |
|
$-0.16M |
|
$7.68M |
|
$5.16M |
|
$9.60M |
|
$4.43M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.64 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.25M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-24.68% |
|
-24.68% |
|
-20.15% |
|
-24.68% |
|
$4.75 |
|
$-1.56 |
|
$-1.49 |
|